Cargando…
Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy
A major obstacle in tumor treatment is associated with the poor penetration of a therapeutic agent into the tumor tissue and with their adverse influence on healthy cells, which limits the dose of drug that can be safely administered to cancer patients. Gemcitabine is an anticancer drug used to trea...
Autores principales: | Hawryłkiewicz, Aleksandra, Ptaszyńska, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828243/ https://www.ncbi.nlm.nih.gov/pubmed/33445797 http://dx.doi.org/10.3390/molecules26020364 |
Ejemplares similares
-
New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets
por: Brankiewicz, Wioletta, et al.
Publicado: (2022) -
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
por: Li, Siwen, et al.
Publicado: (2014) -
Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides
por: Zakeri-Milani, Parvin, et al.
Publicado: (2017) -
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
por: Habib, Saffiya, et al.
Publicado: (2021) -
Design and Application of Antimicrobial Peptide Conjugates
por: Reinhardt, Andre, et al.
Publicado: (2016)